"How Many Patients Could Benefit From Pre-emptive Pharmacogenomic Testing ..."

Wolfgang Kuch et al. (2016)

Details and statistics

DOI: 10.3233/978-1-61499-645-3-253

access: closed

type: Conference or Workshop Paper

metadata version: 2021-04-09

a service of  Schloss Dagstuhl - Leibniz Center for Informatics